아스테라시스

450950KOSDAQ의료용 기기 제조업

52.0 / 100

Reference Date: 2026-06-10

Financial Score26.5 / 40

News Sentiment12.5 / 25

Momentum3.0 / 20

Disclosure10.0 / 15

AI Analysis: the debt ratio is very low with excellent financial health but PBR raises overvaluation concerns. Plunged 32.7% over the past month, with no recent news.

Company InformationBased on 2025 Annual Report

Business Overview

Astersis is a company specializing in the production and sale of medical devices for aesthetic treatments, focusing on high-intensity focused ultrasound (HIFU) and radiofrequency (RF) technologies. Its flagship product, Liftera, stands out for reduced patient discomfort and enhanced efficacy, driving market differentiation. The company is expanding globally through new product development and international certifications, including FDA approval targeting 2025.

Number of Employees

88people

Average Salary

106.7M KRW

Score Calculation Basis

Detailed Financial Score

PER

28.92Industry Average 21.513.0Point

Higher than industry avg (caution)

PBR

5.82Industry Average 1.380.0Point

4.2x industry avg (risky)

ROE

27.74Industry Average 8.007.0Point

3.5x industry avg (excellent)

Debt Ratio

0.39Industry Average 11.658.0Point

Half of industry avg (excellent)

Trend 2024~20258.5 / 10 points

Revenue Growth Rate

3.0 / 3

Avg ▲31.6% (1-year basis)

Operating Profit Growth Rate

3.0 / 3

Avg ▲55.9% (1-year basis)

ROE Trend

2.5 / 4

Avg ROE 34.2% (declining, 2yr)

Detailed News Sentiment

0 totalPositive 0Neutral 0Negative 0

Detailed Momentum

52-week position1.0Point

Near 52w low (0%, downtrend)

Current 7,230Won52-week high 16,10052-week low 7,230

1-month return0.0Point

1m -32.74% (strong drop)

Volume trend2.0Point

Volume decreasing

Detailed Disclosure

3 totalPositive 0Neutral 3Negative 0

Neutral주식등의대량보유상황보고서(일반)2026-06-08
Neutral주식등의대량보유상황보고서(일반)2026-05-15
Neutral분기보고서 (2026.03)2026-05-15